Luis Veloza

493 total citations
17 papers, 180 citations indexed

About

Luis Veloza is a scholar working on Pathology and Forensic Medicine, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Luis Veloza has authored 17 papers receiving a total of 180 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pathology and Forensic Medicine, 8 papers in Oncology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Luis Veloza's work include Lymphoma Diagnosis and Treatment (12 papers), Viral-associated cancers and disorders (6 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Luis Veloza is often cited by papers focused on Lymphoma Diagnosis and Treatment (12 papers), Viral-associated cancers and disorders (6 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Luis Veloza collaborates with scholars based in Spain, Switzerland and Andorra. Luis Veloza's co-authors include Elı́as Campo, Inmaculada Ribera‐Cortada, Armando López‐Guillermo, Antonio Martı́nez, Eva Giné, Blanca González‐Farré, Olga Balagué, Ferran Nadeu, Guillem Clot and Sı́lvia Beà and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and International Journal of Molecular Sciences.

In The Last Decade

Luis Veloza

13 papers receiving 177 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luis Veloza Spain 8 116 100 34 33 30 17 180
Massimo Granai Italy 8 88 0.8× 113 1.1× 32 0.9× 38 1.2× 49 1.6× 28 184
Sheren Younes United States 8 83 0.7× 54 0.5× 44 1.3× 26 0.8× 26 0.9× 19 176
Ana Batlle Spain 7 151 1.3× 115 1.1× 58 1.7× 51 1.5× 28 0.9× 15 248
Mahsa Khanlari United States 9 103 0.9× 114 1.1× 68 2.0× 34 1.0× 34 1.1× 28 205
Edgardo R. Parrilla Castellar United States 6 110 0.9× 93 0.9× 24 0.7× 38 1.2× 41 1.4× 9 257
Verónica Celis Spain 6 79 0.7× 68 0.7× 46 1.4× 21 0.6× 32 1.1× 7 178
Kseniya Petrova‐Drus United States 7 80 0.7× 54 0.5× 43 1.3× 29 0.9× 31 1.0× 20 183
Julián Sánchez Conejo‐Mir Spain 8 78 0.7× 73 0.7× 32 0.9× 28 0.8× 26 0.9× 21 212
Seren Durer United States 8 49 0.4× 141 1.4× 30 0.9× 66 2.0× 68 2.3× 29 273
Sébastian Wittnebel France 9 80 0.7× 136 1.4× 37 1.1× 35 1.1× 117 3.9× 19 260

Countries citing papers authored by Luis Veloza

Since Specialization
Citations

This map shows the geographic impact of Luis Veloza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luis Veloza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luis Veloza more than expected).

Fields of papers citing papers by Luis Veloza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luis Veloza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luis Veloza. The network helps show where Luis Veloza may publish in the future.

Co-authorship network of co-authors of Luis Veloza

This figure shows the co-authorship network connecting the top 25 collaborators of Luis Veloza. A scholar is included among the top collaborators of Luis Veloza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luis Veloza. Luis Veloza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Veloza, Luis, et al.. (2025). Primary solitary fibrous tumor of the liver: an uncommon neoplasm. Gastroenterology report. 13. goaf012–goaf012.
2.
Veloza, Luis, David Vallois, Vimel Rattina, et al.. (2023). TCL-473 Role of Microsatellite Instability in the Oncogenesis of Primary Intestinal T-Cell Lymphomas. Clinical Lymphoma Myeloma & Leukemia. 23. S471–S471.
3.
González‐Farré, Blanca, Joan E. Ramis-Zaldivar, Natalia Castrejón de Anta, et al.. (2022). Intravascular Large B-Cell Lymphoma Genomic Profile Is Characterized by Alterations in Genes Regulating NF-κB and Immune Checkpoints. The American Journal of Surgical Pathology. 47(2). 202–211. 20 indexed citations
5.
Parra‐Medina, Rafael, et al.. (2022). Synchronous or collision solid neoplasms and lymphomas: A systematic review of 308 case reports. Medicine. 101(28). e28988–e28988. 5 indexed citations
6.
Balsas, Patricia, Luis Veloza, Guillem Clot, et al.. (2021). SOX11, CD70, and Treg cells configure the tumor immune microenvironment of aggressive mantle cell lymphoma. Blood. 138(22). 2202–2215. 32 indexed citations
7.
Veloza, Luis, Chun‐Yi Tsai, Bettina Bisig, et al.. (2021). EBV-positive large B-cell lymphoma with an unusual intravascular presentation and associated haemophagocytic syndrome in an HIV-positive patient: report of a case expanding the spectrum of EBV-positive immunodeficiency-associated lymphoproliferative disorders. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 480(3). 699–705. 4 indexed citations
8.
Ribera‐Cortada, Inmaculada, Isabel Trias, Luis Veloza, et al.. (2021). Pathogenesis of Penile Squamous Cell Carcinoma: Molecular Update and Systematic Review. International Journal of Molecular Sciences. 23(1). 251–251. 18 indexed citations
9.
Mozas, Pablo, Ferran Nadeu, Alfredo Rivas‐Delgado, et al.. (2020). Patterns of change in treatment, response, and outcome in patients with follicular lymphoma over the last four decades: a single-center experience. Blood Cancer Journal. 10(3). 31–31. 25 indexed citations
10.
Sanchez, Sandra, Luis Veloza, Armando López‐Guillermo, et al.. (2020). HHV8-positive, EBV-positive Hodgkin lymphoma-like large B cell lymphoma: expanding the spectrum of HHV8 and EBV-associated lymphoproliferative disorders. International Journal of Hematology. 112(5). 734–740. 6 indexed citations
11.
Croci, Giorgio Alberto, Eva Hoster, Sı́lvia Beà, et al.. (2020). Reproducibility of histologic prognostic parameters for mantle cell lymphoma: cytology, Ki67, p53 and SOX11. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 477(2). 259–267. 9 indexed citations
12.
Petrakis, Georgios, Luis Veloza, Guillem Clot, et al.. (2019). Increased tumour angiogenesis in SOX11‐positive mantle cell lymphoma. Histopathology. 75(5). 704–714. 16 indexed citations
13.
Veloza, Luis, Inmaculada Ribera‐Cortada, & Elı́as Campo. (2019). Mantle cell lymphoma pathology update in the 2016 WHO classification. 3. 3–3. 16 indexed citations
15.
Veloza, Luis, Inmaculada Ribera‐Cortada, & Elı́as Campo. (2018). Mantle Cell Lymphoma Biology. Clinical Lymphoma Myeloma & Leukemia. 18. S97–S98. 2 indexed citations
17.
Veloza, Luis, et al.. (2008). Algunos aspectos hereditarios y ambientales en casos de fibrosis quística en la ciudad de Cartagena (Colombia). SHILAP Revista de lepidopterología. 24(1). 10–22.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026